For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Progenity, Inc.

USPTO Granted Patents = 20

% Expired Patents = 15.0

EPO Patents = 13

Trademarks = 2

Forward Citations = 65

Loading Chart...

Loading Chart...

58 inventors (with patents filed for the assignee):

Mitchell Lawrence Jones (10 out of 36 patents)

Sharat Singh (9 out of 100 patents)

Christopher Loren Wahl (6 out of 26 patents)

4. Matthew Sekedat (4 out of 7 patents)

5. Amin R Mazloom (3 out of 15 patents)

6. Mark Sasha Drlik (3 out of 20 patents)

7. Harry Stylli (3 out of 17 patents)

8. Pankaj Oberoi (2 out of 27 patents)

9. Jeffrey A Shimizu (2 out of 7 patents)

10. Jeffrey Buis (2 out of 5 patents)

11. Ronald David Beaubien, Jr (2 out of 7 patents)

12. Jeff Perry (2 out of 5 patents)

13. Jung H Kim (2 out of 2 patents)

14. Heng Wang (2 out of 2 patents)

15. Tobias Mann (2 out of 16 patents)

20 patents: Sort by Forward Citations

1. 12668833 - METHODS, SYSTEMS, AND COMPOSITIONS FOR COUNTING NUCLEIC ACID MOLECULES (2026-06-30),

2. 11333672 - Preeclampsia biomarkers and related systems and methods (2022-05-17),

3. 11327071 - Assessment of preeclampsia using assays for free and dissociated placental growth factor (2022-05-10),

4. 11241562 - Ingestible device with relatively large payload volume (2022-02-08),

5. 11224364 - Ingestible device and associated methods (2022-01-18),

6. 11186863 - Methods, systems, and compositions for counting nucleic acid molecules (2021-11-30),

7. 11134889 - Treatment of a disease of the gastrointestinal tract with a SMAD7 inhibitor (2021-10-05),

8. 11112403 - Assessment of preeclampsia using assays for free and dissociated placental growth factor (2021-09-07),

9. 11033490 - Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devices (2021-06-15),

10. 11007356 - Ingestible device for delivery of therapeutic agent to the gastrointestinal tract (2021-05-18),

11. 10980739 - Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor (2021-04-20),

12. 10947595 - Nucleic acids and methods for detecting chromosomal abnormalities (2021-03-16),

13. 10835152 - Electromechanical pill device with localization capabilities (2020-11-17),

14. 10610104 - Gastrointestinal tract detection methods, devices and systems (2020-04-07),

15. 10588608 - Sampling systems and related materials and methods (2020-03-17),

Progenity, Inc. is a biotechnology company that specializes in developing and commercializing molecular testing products. The company focuses on providing innovative solutions in the fields of reproductive health, oncology, and gastroenterology. Progenity offers a comprehensive suite of testing services to assist healthcare professionals in making informed clinical decisions. With a commitment to advancing precision medicine, Progenity continuously strives to improve patient outcomes through its cutting-edge diagnostic solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

20 Patents

#302 in San Diego, CA

#3,927 in California

#16,363 in US

#31,176 in the World

San Diego, CA, United States of America

Progenity, Inc.

Forward Citations = 65

58 inventors:

Mitchell Lawrence Jones (10 out of 36 patents)

Sharat Singh (9 out of 100 patents)

Christopher Loren Wahl (6 out of 26 patents)

4. Matthew Sekedat (4 out of 7 patents)

5. Amin R Mazloom (3 out of 15 patents)

Please report any incorrect information to [email protected]

Loading…